Michael L. Levitz
Overview
Michael L. Levitz received an average of $2M in total compensation, including $315K in salary, at Anika Therapeutics between 2020 and 2021. Michael Levitz also received an average of $2M at Insulet from 2015 to 2018 and an average of $817K at Analogic from 2009 to 2015.
- 2021
- 2020
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
Anika TherapeuticsEVP, Chief Financial Officer and Treasurer
Anika TherapeuticsEVP, Chief Financial Officer and Treasurer
InsuletSenior Vice President, Treasurer and Chief Financial Officer
InsuletSenior Vice President, Treasurer and Chief Financial Officer
InsuletSenior Vice President, Chief Financial Officer and Treasurer
InsuletSenior Vice President, Chief Financial Officer and Treasurer
AnalogicFormer Senior Vice President, Chief Financial Officer and Treasurer
AnalogicFormer Senior Vice President, Chief Financial Officer and Treasurer
AnalogicFormer Senior Vice President, Chief Financial Officer and Treasurer
AnalogicSenior Vice President, Chief Financial Officer, and Treasurer
Source: SEC filings on April 27, 2022, April 30, 2021, April 12, 2019, April 7, 2017, November 25, 2015, November 27, 2013, November 26, 2012, and November 25, 2011.
Related executives
We found 41 more executives who work or worked at Anika Therapeutics, Insulet, andAnalogic.
Cheryl Blanchard
Anika Therapeutics
Chief Executive Officer
David Colleran
Anika Therapeutics
General Counsel
Thomas Finnerty
Anika Therapeutics
EVP, Human Resources
James Loerop
Anika Therapeutics
EVP, Business Development and Strategic Planning
Sylvia Cheung
Anika Therapeutics
Chief Financial Officer
Joseph Darling
Anika Therapeutics
Chief Executive Officer
Patrick Sullivan
Insulet
Chief Executive Officer
Charles Sherwood
Anika Therapeutics